PortfoliosLab logoPortfoliosLab logo
CPH.TO vs. TVK.TO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CPH.TO vs. TVK.TO - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in Cipher Pharmaceuticals Inc. (CPH.TO) and TerraVest Industries Inc. (TVK.TO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CPH.TO achieves a 11.22% return, which is significantly higher than TVK.TO's -3.55% return. Over the past 10 years, CPH.TO has underperformed TVK.TO with an annualized return of 8.60%, while TVK.TO has yielded a comparatively higher 41.36% annualized return.


CPH.TO

1D
1.39%
1M
-6.42%
YTD
11.22%
6M
14.73%
1Y
36.62%
3Y*
61.86%
5Y*
63.58%
10Y*
8.60%

TVK.TO

1D
4.92%
1M
23.73%
YTD
-3.55%
6M
26.31%
1Y
-5.86%
3Y*
79.78%
5Y*
56.74%
10Y*
41.36%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CPH.TO vs. TVK.TO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CPH.TO
Cipher Pharmaceuticals Inc.
11.22%5.17%158.48%44.27%116.95%90.32%-38.00%-12.28%-65.10%0.00%
TVK.TO
TerraVest Industries Inc.
-3.55%47.85%154.61%62.88%2.14%75.27%26.32%31.99%13.03%9.55%

Correlation

The correlation between CPH.TO and TVK.TO is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.10

Correlation (10Y)
Calculated over the trailing 10-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Feb 26, 2004

0.06

The correlation between CPH.TO and TVK.TO shifts across timeframes, from 0.06 (all time) to 0.17 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CPH.TO:

CA$432.22M

TVK.TO:

CA$3.51B

EPS

CPH.TO:

CA$1.19

TVK.TO:

CA$3.35

PE Ratio

CPH.TO:

14.11

TVK.TO:

47.31

PEG Ratio

CPH.TO:

0.17

TVK.TO:

2.14

PS Ratio

CPH.TO:

8.58

TVK.TO:

2.06

PB Ratio

CPH.TO:

3.25

TVK.TO:

4.64

Total Revenue (TTM)

CPH.TO:

CA$50.92M

TVK.TO:

CA$1.68B

Gross Profit (TTM)

CPH.TO:

CA$37.95M

TVK.TO:

CA$381.90M

EBITDA (TTM)

CPH.TO:

CA$25.12M

TVK.TO:

CA$331.92M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CPH.TO vs. TVK.TO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CPH.TO
CPH.TO Risk / Return Rank: 6868
Overall Rank
CPH.TO Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
CPH.TO Sortino Ratio Rank: 6969
Sortino Ratio Rank
CPH.TO Omega Ratio Rank: 6464
Omega Ratio Rank
CPH.TO Calmar Ratio Rank: 7070
Calmar Ratio Rank
CPH.TO Martin Ratio Rank: 6868
Martin Ratio Rank

TVK.TO
TVK.TO Risk / Return Rank: 3535
Overall Rank
TVK.TO Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
TVK.TO Sortino Ratio Rank: 3434
Sortino Ratio Rank
TVK.TO Omega Ratio Rank: 3434
Omega Ratio Rank
TVK.TO Calmar Ratio Rank: 3535
Calmar Ratio Rank
TVK.TO Martin Ratio Rank: 3535
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CPH.TO vs. TVK.TO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cipher Pharmaceuticals Inc. (CPH.TO) and TerraVest Industries Inc. (TVK.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CPH.TOTVK.TODifference
Sharpe ratioReturn per unit of total volatility

+0.95

Sortino ratioReturn per unit of downside risk

+1.52

Omega ratioGain probability vs. loss probability

1.19

1.02

+0.17

Calmar ratioReturn relative to maximum drawdown

1.52

-0.19

+1.71

Martin ratioReturn relative to average drawdown

3.23

-0.34

+3.56

CPH.TO vs. TVK.TO - Sharpe Ratio Comparison

The current CPH.TO Sharpe Ratio is 0.82, which is higher than the TVK.TO Sharpe Ratio of -0.13. The chart below compares the historical Sharpe Ratios of CPH.TO and TVK.TO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CPH.TOTVK.TODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.82

-0.13

+0.95

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.28

1.52

-0.24

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.14

1.25

-1.11

Sharpe Ratio (All Time)

Calculated using the full available price history

0.08

0.37

-0.29

Drawdowns

CPH.TO vs. TVK.TO - Drawdown Comparison

The maximum CPH.TO drawdown since its inception was -97.90%, which is greater than TVK.TO's maximum drawdown of -84.33%. Use the drawdown chart below to compare losses from any high point for CPH.TO and TVK.TO.


Loading charts...

Drawdown Indicators


CPH.TOTVK.TODifference

Max Drawdown

Largest peak-to-trough decline

-97.90%

-84.33%

-13.57%

Max Drawdown (1Y)

Largest decline over 1 year

-22.83%

-31.96%

+9.13%

Max Drawdown (3Y)

Largest decline over 3 years

-42.50%

-31.96%

-10.54%

Max Drawdown (5Y)

Largest decline over 5 years

-42.50%

-31.96%

-10.54%

Max Drawdown (10Y)

Largest decline over 10 years

-94.64%

-41.58%

-53.06%

Current Drawdown

Current decline from peak

-15.15%

-9.08%

-6.07%

Average Drawdown

Average peak-to-trough decline

-61.46%

-24.94%

-36.52%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.77%

17.98%

-7.21%

Volatility

CPH.TO vs. TVK.TO - Volatility Comparison

The current volatility for Cipher Pharmaceuticals Inc. (CPH.TO) is 13.90%, while TerraVest Industries Inc. (TVK.TO) has a volatility of 15.59%. This indicates that CPH.TO experiences smaller price fluctuations and is considered to be less risky than TVK.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CPH.TOTVK.TODifference

Volatility (1M)

Calculated over the trailing 1-month period

13.90%

15.59%

-1.69%

Volatility (6M)

Calculated over the trailing 6-month period

28.46%

38.70%

-10.24%

Volatility (1Y)

Calculated over the trailing 1-year period

42.66%

45.69%

-3.03%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

49.98%

37.90%

+12.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

60.76%

35.13%

+25.63%

Dividends

CPH.TO vs. TVK.TO - Dividend Comparison

CPH.TO has not paid dividends to shareholders, while TVK.TO's dividend yield for the trailing twelve months is around 0.47%.


PositionTTM20252024202320222021202020192018201720162015
CPH.TO
Cipher Pharmaceuticals Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TVK.TO
TerraVest Industries Inc.
0.47%0.44%0.56%1.19%1.54%1.46%2.50%3.08%3.94%4.28%4.49%5.63%

Financials

CPH.TO vs. TVK.TO - Financials Comparison

This section allows you to compare key financial metrics between Cipher Pharmaceuticals Inc. and TerraVest Industries Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M20222023202420252026
12.30M
442.57M
(CPH.TO) Total Revenue
(TVK.TO) Total Revenue
Values in CAD except per share items

CPH.TO vs. TVK.TO - Profitability Comparison

The chart below illustrates the profitability comparison between Cipher Pharmaceuticals Inc. and TerraVest Industries Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20222023202420252026
67.9%
20.5%
Portfolio components
CPH.TO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cipher Pharmaceuticals Inc. reported a gross profit of 8.35M and revenue of 12.30M. Therefore, the gross margin over that period was 67.9%.

TVK.TO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TerraVest Industries Inc. reported a gross profit of 90.64M and revenue of 442.57M. Therefore, the gross margin over that period was 20.5%.

CPH.TO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cipher Pharmaceuticals Inc. reported an operating income of 5.50M and revenue of 12.30M, resulting in an operating margin of 44.7%.

TVK.TO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TerraVest Industries Inc. reported an operating income of 34.19M and revenue of 442.57M, resulting in an operating margin of 7.7%.

CPH.TO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cipher Pharmaceuticals Inc. reported a net income of 6.06M and revenue of 12.30M, resulting in a net margin of 49.3%.

TVK.TO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TerraVest Industries Inc. reported a net income of 10.04M and revenue of 442.57M, resulting in a net margin of 2.3%.


Frequently Asked Questions


CPH.TO and TVK.TO have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for CPH.TO and TVK.TO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer